{
    "title": "Eli Lilly appoints new obesity unit head ahead of key Mounjaro decision",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12592891/Eli-Lillys-head-diabetes-obesity-unit-retire.html",
    "date": "2023-10-04",
    "keywords": [
        "obesity",
        "mounjaro",
        "jonsson",
        "drug",
        "chief",
        "unit",
        "treatment",
        "tirzepatide",
        "mason",
        "role",
        "division",
        "latestage",
        "development",
        "companys",
        "lillys",
        "wednesday",
        "string",
        "leadership",
        "decision",
        "use",
        "blockbuster",
        "weightloss",
        "patrik",
        "president",
        "jan",
        "mike",
        "head",
        "nextgeneration",
        "retatrutide",
        "pill",
        "drugmaker",
        "immunology",
        "scandinavia",
        "italy",
        "japan",
        "launch",
        "quarter",
        "class",
        "glp1s",
        "insulin",
        "production",
        "market",
        "decade",
        "officer",
        "daniel",
        "skovronsky",
        "responsibility",
        "premarket",
        "trading",
        "stock",
        "year",
        "investor",
        "success",
        "reporting",
        "bhanvi",
        "satija",
        "bengaluru",
        "editing",
        "dsouza",
        "sherry"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}